report by BlackRock
Results for ""
Sustainable Investing
Think Sustainable
This investor guide answers four key questions to help get started with sustainable investing.
Sustainable Investing
Introducing sustainability in portfolios
Explore BlackRock’s framework for introducing sustainability in portfolios.
Sustainable Investing
International Women’s Day: Women at the heart of the COVID-19 recovery
This piece is approved to use with clients.
We celebrate this year’s International Women’s Day whilst at a critical juncture for global gender equality.Although recent years have seen progress on, for example, female presentation in leadership positions, the Covid-19 pandemic has laid bare and deepened already existing inequities
Retirement
Can I invest my IRA in this?
This piece is approved to use with clients.
Alternative assets, such as cryptocurrencies, art, private equity and more, have seen a surge in press coverage over the past decade, to the point that many of these alternative investments have become more mainstream than ever before.
Sustainable Investing
2019–2020 Responsible Investing Engagement Report
This piece is approved to use with clients.
The 2019-2020 Responsible Investing Engagement Report chronicles Nuveen's active-ownership initiatives and the outcomes achieved over the past year.
Client Relationships
Help Your Clients Understand the Markets and Their Portfolios
While the markets have seemingly recovered from the early impact of COVID-19, the past few months have been a reminder that unpredictability is a part of investing, and downturns are inevitable.
Sustainable Investing
Influencing for good: 20 years of engagement
This piece is approved to use with clients.
The way investors conduct engagement has transformed. From a niche approach largely confined to mission-orientated investors, engagement is now a mainstream investor activity. The success of the Climate Action 100+ initiative in bringing together investors, representing close to US$40 trillion in assets, shows how far we have come.
Sustainable Investing
ESG Viewpoint – COVID-19 and the pharmaceutical industry
This piece is approved to use with clients.
Public trust in the pharmaceutical industry has eroded. The pandemic provides drug-makers a chance to begin re-building their reputation – but only if they prioritise socially responsible practices.